The lungs have received attention as a portal for drug delivery in tuberculosis (TB) from
researchers addressing diverse objectives. These include:(a) targeting alveolar …

Pulmonary diseases pose an immense threat to global health. Several nanotherapeutics-
based approaches aimed to tackle pulmonary ailments in recent years. The current …

We investigated the toxic effects of inhalation exposure to ferric oxide (Fe2O3) and zinc
oxide (ZnO) nanoparticles in rats. Male Wistar rats were consecutively treated with Fe2O3 at …

Pulmonary drug delivery system is increasingly gaining popularity for several lung diseases
including tuberculosis (TB) due to its ability to attain high drug concentrations at the site of …

In the global context of an imminent emergence of multidrug-resistant microorganisms, the
present work combined the use of nanotechnology and the therapeutic benefits of natural …

Intracellular concentrations of isoniazid and rifabutin resulting from administration of
inhalable microparticles of these drugs to phorbol-differentiated THP-1 cells and the …

Lung cancer is one of the most fatal malignancies, with the highest death rate (∼ 19%), and
the NSCLC type accounts for∼ 85% of lung cancers. In the search for new treatments …

Inhalable clofazimine-containing dry powder microparticles (CFM-DPI) and native
clofazimine (CFM) were evaluated for activity against Mycobacterium tuberculosis in human …

The growing interest on polymeric delivery systems for pulmonary administration of drugs
anticipates a more direct and efficient treatment of diseases such as tuberculosis (TB) that …

Background Favipiravir is administered orally, even against airborne RNA viruses, in a
loading-dose/maintenance dose regimen. We investigated whether—(a) pulmonary delivery …